HomeREGULATORY
REGULATORY

Industry Casts Doubt on “1.25 Times” Threshold for Downward Tweak under Foreign Price Adjustment Rule
(Dec.12.2016)

Pharma Industry Rep Kamoya (right)
A key pharma industry official on December 9 questioned the reasonability of the current “1.25 times” threshold for downward adjustments under the average foreign price rule, which is used in the initial price-setting of newly approved drugs ...
(LOG IN FOR FULL STORY)

News Calendar